Caldera Medical acquires Ireland-based Atlantic Therapeutics to boost pelvic health solutions

Caldera Medical, a medical device company specializing in women’s health, announced the completion of its acquisition of Ireland-based Atlantic Therapeutics. The deal adds Atlantic Therapeutics’ FDA-cleared Innovo product family to Caldera Medical‘s offerings, particularly for women suffering from stress urinary incontinence (SUI). Caldera Medical will also establish a European headquarters in Galway, Ireland.

Expanding the Portfolio in Women’s Health

Bryon Merade, CEO of Caldera Medical, stated, “We are thrilled to acquire Atlantic Therapeutics and scale the rapidly growing Innovo products worldwide. This acquisition aligns perfectly with our mission and allows us to offer an even more comprehensive suite of solutions to healthcare providers and patients alike.” Atlantic Therapeutics brings a range of non-invasive pelvic floor strengthening and nerve-stimulating devices, backed by robust clinical evidence and randomized controlled trials, to Caldera Medical’s expanding portfolio.

A Milestone for Atlantic Therapeutics and its Innovo Product Line

Susan Trent, CEO of Atlantic Therapeutics, commented, “Since its formation, the team at Atlantic Therapeutics has demonstrated the huge potential of Innovo. This unique technology with robust clinical data is ideally placed to serve the millions of women worldwide who suffer the daily distress of SUI. Caldera Medical’s ability to maximize this potential is the perfect next step. I am delighted that we will see Innovo thrive within Caldera Medical and want to thank Bryon and the team for their dedication to women’s health.” Healthcare professionals worldwide depend on Atlantic Therapeutics’ solutions to improve the quality of life for tens of thousands of patients each year.

What This Means for the Future of Women’s Health Solutions

The acquisition sets the stage for Caldera Medical to further its mission of improving the quality of life for women by offering a broader array of treatments for stress urinary incontinence, pelvic organ prolapse, polyps, and fibroids. By maintaining a European headquarters in Ireland, Caldera Medical aims to strengthen its global reach in the women’s health sector.

The merger of these two companies signals a significant move in the medical device industry, particularly in women’s health, as it brings together Caldera Medical’s expertise in surgical solutions with Atlantic Therapeutics’ strength in non-invasive treatments.